Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061290/0203 | |
| Pages: | 4 |
| | Recorded: | 10/03/2022 | | |
| Attorney Dkt #: | 103514-US-CNT[8] |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/25/2023
|
Application #:
|
17821833
|
Filing Dt:
|
08/24/2022
|
|
Publication #:
|
|
Pub Dt:
|
01/05/2023
| | | | |
|
Title:
|
IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
|
|
|
Assignee
|
|
|
|
|
| 1 FRANCIS CRICK AVENUE |
| CAMBRIDGE BIOMEDICAL CAMPUS |
| CAMBRIDGE, ENGLAND CB2 0AA |
|
|
Correspondence name and address
|
| |
ASTRAZENECA PHARMACEUTICALS
|
| |
ONE MEDIMMUNE WAY
|
| |
GAITHERSBURG, MD 20878
|
Search Results as of:
05/24/2024 11:06 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
